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Background
Multiple studies have shown that colorectal cancer
(CRC) disparities exist between African Americans and
Caucasians. African Americans have higher CRC inci-
dence and mortality than Caucasians [1,2]. Furthermore,
African Americans present with more advanced CRC [3]
and at younger ages [4]. However, little is known about
the impact of hereditary CRC syndromes in African
Americans on these disparities. In the University of Chi-
cago Cancer Risk Clinic, we see a diverse referral popu-
lation for evaluation of hereditary syndromes based on
personal or family history of CRC. We sought to com-
pare clinical characteristics of our African American and
Caucasian patients to determine if differences exist in a
high-risk CRC referral population.
Method
We retrospectively collected data on self-reported Afri-
can American and Caucasian individuals who were
referred for a personal or family history of CRC from
1992-2010. Available clinical characteristics including
number of individuals, number of families (probands
with family members who followed-up in our clinic),
personal or family history of CRC, age at cancer onset,
and number of individuals who underwent genetic test-
ing for APC or mismatch repair genes were collected.
Pedigrees were reviewed to determine Revised Bethesda,
Amsterdam II and PREMM1,2 scores. Statistical analysis
included Student’s t-test for continuous variables and
Pearson’sc h i - s q u a r ef o rc a t e g o r i cal variables. Compari-
son of independent proportions was done using z-ratios.
Results
A total of 949 Caucasian and 254 African American
individuals were referred to the Cancer Risk Clinic for a
personal or family history of CRC. The average age of
CRC diagnosis, number of family members with CRC,
and those meeting Bethesda and Amsterdam criteria
were similar between populations (Table 1). Fewer
family members of African American probands were
seen compared to Caucasians (p =0.002). More African
American females with CRC were seen in our clinic
(p=0.04). Importantly, despite overall similar clinical
characteristics, fewer African Americans had genetic
testing compared to Caucasians (p = 0.02).
Conclusion
Despite many similarities between our high-risk CRC
populations, there exists a difference in the number of
family members of African American probands seen in
our clinic and the number of African Americans who
had genetic testing when compared to Caucasians. Less
genetic testing may mean African American mutation
carriers are not being identified. This can significantly
impact appropriate cancer screening recommendations
and knowledge about hereditary CRC syndromes in this
population. Future collaborative studies are needed to
address why these differences may exist.
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Table 1 Clinical characteristics of individuals referred for personal and/or family history of CRC by race
AA Caucasian p-value
Personal and/or family history of CRC
Total number of individuals 254 949
Total number families (% of total individuals) 68 (26.8) 617 (65.0) 0.002
Median # CRC affected family members (range) 1 (1-7) 1 (1-14)
Average number CRC affected family members < 50 years 0.35 0.46
Number with polyps (%) 6 (2.4) 43 (4.5) 0.12
Genetic testing (%) 16 (6.3) 106 (11.2) 0.02
Personal History of CRC
Total number (% of total) 32 (12.6) 86 (9.1) 0.09
Age years (mean) 48.6 49.9 0.65
% female 82.1 60.5 0.04
Revised Bethesda + (%) 22 (68.8) 49 (57.0) 0.25
Amsterdam II + (%) 5 (15.6) 17 (19.8) 0.61
PREMM1,2 score 17.06 16.12 0.81
Genetic testing (%) 10 (31.2) 42 (48.8) 0.09
CRC, colorectal cancer; AA, African American; Genetic testing category includes mismatch repair genes and APC; PREMM1,2 score obtained using publicly
available calculator.
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